Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 - case report and review of the literature

• Published in: Clinical endocrinology (Oxford) Vol. 84; no. 2; pp. 244 - 249
• Main Authors: Singh Ospina, Naykky, Sebo, Thomas J., Thompson, Geoffrey B., Clarke, Bart L., Young Jr, William F.
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01-02-2016; Wiley Subscription Services, Inc
• ISSN: 0300-0664; 1365-2265
• DOI: 10.1111/cen.12714

Summary
Objective
To report the prevalence of parathyroid carcinoma (PC) in patients with multiple endocrine neoplasia type 1 (MEN1) and review of the literature.
Background
Primary hyperparathyroidism (PHP) is the most common manifestation of MEN1. The occurrence of PC in patients with MEN1 is rare and the literature regarding the clinical manifestations – including the prevalence of the disease – is scarce.
Context
Single tertiary care centre experience from 1977 to 2013.
Design
Electronic search of the medical records to identify a cohort of patients with MEN1. Literature review based on current case reports.
Patients
Single case of PC in a cohort of 348 patients with MEN1. Ten cases of PC in patients with MEN1 reported in the literature.
Measurement
Clinical features of PC in patients with MEN1.
Results
The prevalence of PC in 348 patients with MEN1 was found to be 0·28% (95% CI, 0–1·4%). Based on the current published cases of PC in patients with MEN1, 54·5% were women, mean age at diagnosis was 48·3 years, and the serum PTH concentrations at least four times the upper limit of the reference range in 73% of the cases.
Conclusion
PC in patients with MEN 1 is rare with a prevalence of 0·28%, and the clinical features are similar to PC in patients without MEN1.